UK government LSIMF's support accelerates investment, strengthening domestic life sciences manufacturing and local job creation. Expanded capacity enables Codis' customers to bring more ...
Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...
ST. LOUIS, March 4, 2026 /PRNewswire/ -- Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced ...
This investment is supported by the UK government's Life Sciences Innovative Manufacturing Fund (LSIMF), subject to final agreement of terms and conditions, which offers up to £520 million in capital ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results